Benzinga - Tue, 04 May 2021 06:28:03 -0400
Benzinga - Tue, 27 Apr 2021 10:20:55 -0400
Benzinga - Tue, 13 Apr 2021 08:33:18 -0400
Benzinga - Mon, 12 Apr 2021 05:10:38 -0400
Benzinga - Fri, 09 Apr 2021 12:02:10 -0400
Benzinga - Fri, 26 Mar 2021 07:37:54 -0400
load more
Sector: Health Care.Industry: Biotechnology
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. The company has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-18
REV
Q4 2020Est.ActualSurprise
EPS-1.010
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ZNTLZentalis Pharmaceuticals7.89%2.4B

Zentalis Pharmaceuticals Company Questions & Answers

Q

How do I buy Zentalis Pharmaceuticals (ZNTL) stock?

A

You can purchase shares of Zentalis Pharmaceuticals (NASDAQ: ZNTL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Zentalis Pharmaceuticals's (ZNTL) main competitors?

A

Other companies in Zentalis Pharmaceuticals’s space includes: bluebird bio (NASDAQ:BLUE), OPKO Health (NASDAQ:OPK) and Xencor (NASDAQ:XNCR).

Q

What is the target price for Zentalis Pharmaceuticals?

A

The latest price target for Zentalis Pharmaceuticals (NASDAQ: ZNTL) was reported by SVB Leerink on 2021-04-13. The analyst firm set a price target for 64.00 expecting ZNTL to rise to within 12 months (a possible 8.14% upside). 8 analyst firms have reported ratings in the last year.

Q

How much is Zentalis Pharmaceuticals (ZNTL) stock ?

A

The stock price for Zentalis Pharmaceuticals (NASDAQ: ZNTL) is $59.18 last updated Fri May 07 2021 20:00:01 GMT+0000 (Coordinated Universal Time).

Q

When is the next Zentalis Pharmaceuticals (ZNTL) dividend?

A

There are no upcoming dividends for Zentalis Pharmaceuticals.

Q

When is Zentalis Pharmaceuticals (NASDAQ:ZNTL) reporting earnings?

A
Zentalis Pharmaceuticals’s Q1 earnings are confirmed after-market from now on May 18, 2021.
Q

When is the upcoming split for ZNTL?

A

There is no upcoming split for Zentalis Pharmaceuticals.